This article reviews the efficacy and safety of flibanserin, a treatment for generalized acquired hypoactive sexual desire disorder (HSDD) in premenopausal women. The review found that flibanserin improved satisfying sexual events and sexual function, as measured by the Female Sexual Function Index and the Female Sexual Distress Scale. However, the
